<DOC>
	<DOCNO>NCT01039896</DOCNO>
	<brief_summary>The aim study ass whether HKB0701 alters pharmacokinetics SLM0807 .</brief_summary>
	<brief_title>A Drug Interaction Study SLM0807 HKB0701 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Healthy volunteer age range 2050years weight range exceed Â±20 % ideal weight . Ideal weight = [ height 100 ] *0.9 Subjects history significant chronic disease Judged good health basis vital sign , ECG , physical exam routine laboratory data Available entire study period Willing adhere protocol requirement sign inform consent form . Subjects take drug induce inhibit hepatic enzyme activity within 30days prior drug administration Subjects symptom acute illness within 4 week prior drug administration Subjects history clinically significant allergy include drug allergy Subjects whose clinical laboratory test value outside accept normal range ( Especially , AST ALT &gt; 1.25 time normal range total bilirubin &gt; 1.5times normal range ) Subjects history drug , caffeine alcohol abuse ( caffeine drink &gt; 5cups /day , alcohol &gt; 30g/day ) Heavy smoker ( &gt; 10cigarettes/day ) Subjects diet know interfere absorption , distribution , metabolism excretion drug ( especially , consumption grapefruit juice ) Subjects donate plasma within 60days prior drug administration Subjects participate clinical study within 90days prior drug administration Subjects receive drug might confound result trial opinion principal investigator ( cimetidine within 7days prior drug administration ) Female subject pregnant , breastfeed use medically acceptable birth control</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>